+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Veterinary Therapeutics Market Research Report by Product (Drug Type, Medicated Feed Additive, and Vaccines Type), Route of Administration, Animal, End User, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 140 Pages
  • July 2022
  • Region: United States
  • 360iResearch™
  • ID: 5124434
UP TO OFF until Dec 31st 2022
The United States Veterinary Therapeutics Market size was estimated at USD 6,762.31 million in 2021, USD 7,604.03 million in 2022, and is projected to grow at a CAGR 8.93% to reach USD 11,303.12 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Veterinary Therapeutics to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Drug Type, Medicated Feed Additive, and Vaccines Type. The Drug Type is further studied across Anti-Inflammatory, Anti-Invectives, and Parasiticides. The Medicated Feed Additive is further studied across Amino Acids, Antibiotics, Online Pharmacy, and Retail Pharmacy. The Vaccines Type is further studied across Recombinant Vaccines, Attenuated Vaccines, and Inactivated Vaccines.
  • Based on Route of Administration, the market was studied across Oral, Parenteral, and Topical.
  • Based on Animal, the market was studied across Companion Animal and Livestock Animal.
  • Based on End User, the market was studied across Pharmacies & Drug Store, Veterinary Clinic, and Veterinary Hospital.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Veterinary Therapeutics market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Veterinary Therapeutics Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Veterinary Therapeutics Market, including Biogenesis Bago, Biovac, Boehringer Ingelheim Vetmedica, Inc., Ceva Santé Animale, Chanelle Pharma, Dechra Animal Health, Elanco Animal Health Incorporated, Eli Lilly and Company, Heska Corp., Hester Biosciences, IDEXX Laboratories Inc., ImmuCell Corporation, Indian Immunologicals Ltd., Kindred Biosciences, Inc., Merck & Co. Inc., Neogen Corporation, Novartis International AG, Nutreco N.V., Philbro Animal Health, Sanofi S.A., Vetoquinol S.A., Virbac S.A., and Zoetis, Inc.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the United States Veterinary Therapeutics Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Veterinary Therapeutics Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Veterinary Therapeutics Market?
4. What is the competitive strategic window for opportunities in the United States Veterinary Therapeutics Market?
5. What are the technology trends and regulatory frameworks in the United States Veterinary Therapeutics Market?
6. What is the market share of the leading vendors in the United States Veterinary Therapeutics Market?
7. What modes and strategic moves are considered suitable for entering the United States Veterinary Therapeutics Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Veterinary Therapeutics Market, by Product
6.1. Introduction
6.2. Drug Type
6.2.1. Anti-Inflammatory
6.2.2. Anti-Invectives
6.2.3. Parasiticides
6.3. Medicated Feed Additive
6.3.1. Amino Acids
6.3.2. Antibiotics
6.3.3. Online Pharmacy
6.3.4. Retail Pharmacy
6.4. Vaccines Type
6.4.1. Recombinant Vaccines
6.4.2. Attenuated Vaccines
6.4.3. Inactivated Vaccines
7. Veterinary Therapeutics Market, by Route of Administration
7.1. Introduction
7.2. Oral
7.3. Parenteral
7.4. Topical
8. Veterinary Therapeutics Market, by Animal
8.1. Introduction
8.2. Companion Animal
8.3. Livestock Animal
9. Veterinary Therapeutics Market, by End-user
9.1. Introduction
9.2. Pharmacies & Drug Store
9.3. Veterinary Clinic
9.4. Veterinary Hospital
10. California Veterinary Therapeutics Market11. Florida Veterinary Therapeutics Market12. Illinois Veterinary Therapeutics Market13. New York Veterinary Therapeutics Market14. Ohio Veterinary Therapeutics Market15. Pennsylvania Veterinary Therapeutics Market16. Texas Veterinary Therapeutics Market
17. Competitive Landscape
17.1. Fpnv Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, by Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion
18. Company Usability Profiles
18.1. Biogenesis Bago
18.2. Biovac
18.3. Boehringer Ingelheim Vetmedica, Inc.
18.4. Ceva Santé Animale
18.5. Chanelle Pharma
18.6. Dechra Animal Health
18.7. Elanco Animal Health Incorporated
18.8. Eli Lilly and Company
18.9. Heska Corp.
18.10. Hester Biosciences
18.11. Idexx Laboratories Inc.
18.12. Immucell Corporation
18.13. Indian Immunologicals Ltd.
18.14. Kindred Biosciences, Inc.
18.15. Merck & Co. Inc.
18.16. Neogen Corporation
18.17. Novartis International Ag
18.18. Nutreco N.V.
18.19. Philbro Animal Health
18.20. Sanofi S.A.
18.21. Vetoquinol S.A.
18.22. Virbac S.A.
18.23. Zoetis, Inc
19. Appendix
19.1. Discussion Guide
19.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES VETERINARY THERAPEUTICS MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY STATE, 2027
FIGURE 7. UNITED STATES VETERINARY THERAPEUTICS MARKET DYNAMICS
FIGURE 8. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2027
FIGURE 11. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, 2019-2027 (USD MILLION)
FIGURE 12. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 13. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ANTI-INFLAMMATORY, 2019-2027 (USD MILLION)
FIGURE 14. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ANTI-INFLAMMATORY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 15. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ANTI-INVECTIVES, 2019-2027 (USD MILLION)
FIGURE 16. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ANTI-INVECTIVES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 17. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY PARASITICIDES, 2019-2027 (USD MILLION)
FIGURE 18. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY PARASITICIDES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 19. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, 2019-2027 (USD MILLION)
FIGURE 20. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 21. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY AMINO ACIDS, 2019-2027 (USD MILLION)
FIGURE 22. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY AMINO ACIDS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 23. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, 2019-2027 (USD MILLION)
FIGURE 24. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 25. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, 2019-2027 (USD MILLION)
FIGURE 26. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 27. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, 2019-2027 (USD MILLION)
FIGURE 28. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 29. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, 2019-2027 (USD MILLION)
FIGURE 30. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 31. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY RECOMBINANT VACCINES, 2019-2027 (USD MILLION)
FIGURE 32. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY RECOMBINANT VACCINES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 33. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ATTENUATED VACCINES, 2019-2027 (USD MILLION)
FIGURE 34. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ATTENUATED VACCINES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 35. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY INACTIVATED VACCINES, 2019-2027 (USD MILLION)
FIGURE 36. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY INACTIVATED VACCINES, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 37. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (%)
FIGURE 38. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (USD MILLION)
FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2027
FIGURE 40. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ORAL, 2019-2027 (USD MILLION)
FIGURE 41. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ORAL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 42. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2019-2027 (USD MILLION)
FIGURE 43. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY PARENTERAL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 44. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY TOPICAL, 2019-2027 (USD MILLION)
FIGURE 45. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY TOPICAL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 46. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2021 VS 2027 (%)
FIGURE 47. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2021 VS 2027 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2027
FIGURE 49. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY COMPANION ANIMAL, 2019-2027 (USD MILLION)
FIGURE 50. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY COMPANION ANIMAL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 51. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY LIVESTOCK ANIMAL, 2019-2027 (USD MILLION)
FIGURE 52. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY LIVESTOCK ANIMAL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 53. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 54. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 55. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2027
FIGURE 56. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY PHARMACIES & DRUG STORE, 2019-2027 (USD MILLION)
FIGURE 57. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY PHARMACIES & DRUG STORE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 58. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY VETERINARY CLINIC, 2019-2027 (USD MILLION)
FIGURE 59. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY VETERINARY CLINIC, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 60. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY VETERINARY HOSPITAL, 2019-2027 (USD MILLION)
FIGURE 61. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY VETERINARY HOSPITAL, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 62. CALIFORNIA VETERINARY THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. FLORIDA VETERINARY THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. ILLINOIS VETERINARY THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. NEW YORK VETERINARY THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. OHIO VETERINARY THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. PENNSYLVANIA VETERINARY THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. TEXAS VETERINARY THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. UNITED STATES VETERINARY THERAPEUTICS MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 70. UNITED STATES VETERINARY THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 71. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES VETERINARY THERAPEUTICS MARKET, BY TYPE
List of Tables
TABLE 1. UNITED STATES VETERINARY THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 5. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY DRUG TYPE, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ANTI-INFLAMMATORY, BY STATE, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ANTI-INVECTIVES, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY PARASITICIDES, BY STATE, 2019-2027 (USD MILLION)
TABLE 10. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY MEDICATED FEED ADDITIVE, BY STATE, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY AMINO ACIDS, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ANTIBIOTICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 15. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY VACCINES TYPE, BY STATE, 2019-2027 (USD MILLION)
TABLE 16. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY RECOMBINANT VACCINES, BY STATE, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ATTENUATED VACCINES, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY INACTIVATED VACCINES, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 20. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ORAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 21. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY PARENTERAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY TOPICAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY COMPANION ANIMAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY LIVESTOCK ANIMAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 26. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY PHARMACIES & DRUG STORE, BY STATE, 2019-2027 (USD MILLION)
TABLE 28. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY VETERINARY CLINIC, BY STATE, 2019-2027 (USD MILLION)
TABLE 29. UNITED STATES VETERINARY THERAPEUTICS MARKET SIZE, BY VETERINARY HOSPITAL, BY STATE, 2019-2027 (USD MILLION)
TABLE 30. CALIFORNIA VETERINARY THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 31. CALIFORNIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 32. CALIFORNIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 33. CALIFORNIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2019-2027 (USD MILLION)
TABLE 34. CALIFORNIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 35. FLORIDA VETERINARY THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 36. FLORIDA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 37. FLORIDA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 38. FLORIDA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2019-2027 (USD MILLION)
TABLE 39. FLORIDA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 40. ILLINOIS VETERINARY THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 41. ILLINOIS VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 42. ILLINOIS VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 43. ILLINOIS VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2019-2027 (USD MILLION)
TABLE 44. ILLINOIS VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 45. NEW YORK VETERINARY THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 46. NEW YORK VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 47. NEW YORK VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 48. NEW YORK VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2019-2027 (USD MILLION)
TABLE 49. NEW YORK VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 50. OHIO VETERINARY THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 51. OHIO VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 52. OHIO VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 53. OHIO VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2019-2027 (USD MILLION)
TABLE 54. OHIO VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 55. PENNSYLVANIA VETERINARY THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 56. PENNSYLVANIA VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 57. PENNSYLVANIA VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 58. PENNSYLVANIA VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2019-2027 (USD MILLION)
TABLE 59. PENNSYLVANIA VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 60. TEXAS VETERINARY THERAPEUTICS MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 61. TEXAS VETERINARY THERAPEUTICS MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 62. TEXAS VETERINARY THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD MILLION)
TABLE 63. TEXAS VETERINARY THERAPEUTICS MARKET SIZE, BY ANIMAL, 2019-2027 (USD MILLION)
TABLE 64. TEXAS VETERINARY THERAPEUTICS MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 65. UNITED STATES VETERINARY THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 66. UNITED STATES VETERINARY THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 67. UNITED STATES VETERINARY THERAPEUTICS MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 68. UNITED STATES VETERINARY THERAPEUTICS MARKET RANKING
TABLE 69. UNITED STATES VETERINARY THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2021
TABLE 70. UNITED STATES VETERINARY THERAPEUTICS MARKET MERGER & ACQUISITION
TABLE 71. UNITED STATES VETERINARY THERAPEUTICS MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 72. UNITED STATES VETERINARY THERAPEUTICS MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 73. UNITED STATES VETERINARY THERAPEUTICS MARKET INVESTMENT & FUNDING
TABLE 74. UNITED STATES VETERINARY THERAPEUTICS MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 75. UNITED STATES VETERINARY THERAPEUTICS MARKET: LICENSE & PRICING

Companies Mentioned

  • Biogenesis Bago
  • Biovac
  • Boehringer Ingelheim Vetmedica, Inc.
  • Ceva Santé Animale
  • Chanelle Pharma
  • Dechra Animal Health
  • Elanco Animal Health Incorporated
  • Eli Lilly and Company
  • Heska Corp.
  • Hester Biosciences
  • IDEXX Laboratories Inc.
  • ImmuCell Corporation
  • Indian Immunologicals Ltd.
  • Kindred Biosciences, Inc.
  • Merck & Co. Inc.
  • Neogen Corporation
  • Novartis International AG
  • Nutreco N.V.
  • Philbro Animal Health
  • Sanofi S.A.
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis, Inc

Methodology

Loading
LOADING...